AbbVie Pharmaceuticals founded in 2013. It separated the company from Abbott and shares a common legacy and strong prospects for future success.
The company formed a new kind of enterprise a biopharmaceutical company. It blends the stability, global scale, resources and commercial capabilities of a pharmaceutical company with the focus and culture of biotech. It takes on the toughest health challenges and aims to make a remarkable impact on people’s lives.
It is a highly focused research-driven biopharmaceutical company with 30,000 employees includes scientists, researchers, communicators, manufacturing specialists and regulatory experts present around the globe. AbbVie Pharmaceuticals comes up with new approaches to addressing today’s health issues from life-threatening illness to chronic conditions.
The company targets specific difficult-to-cure diseases where it can leverage its core R&D expertise to advance science. It constantly working to create solutions that go beyond treating the illness that impacts positively on people’s lives, on societies and on science itself.
The purpose of the company is profound, and its path is clear. AbbVie Pharmaceuticals embraces the responsibility of making a remarkable impact on people's lives through innovative medicines and solutions. This is driven by the company’s compassion for people, commitment to innovation or inclusion, service to the community, and uncompromising integrity at the heart of everything the company does.